Increased prevalence of clonal hematopoiesis of indeterminate potential in hospitalized patients with COVID-19

Clonal hematopoiesis of indeterminate potential (CHIP) leads to higher mortality, carries a cardiovascular risk and alters inflammation. All three aspects harbor overlaps with the clinical manifestation of COVID-19. This study aimed to identify the impact of CHIP on COVID-19 pathophysiology. 90 hosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Schenz, Judith, Rump, Katharina, Siegler, Benedikt Hermann, Hemmerling, Inga, Rahmel, Tim, Thon, Jan N., Nowak, Hartmuth, Fischer, Dania, Hafner, Anna, Tichy, Lucas, Bomans, Katharina, Meggendorfer, Manja, Koos, Björn, von Groote, Thilo, Zarbock, Alexander, Fiedler, Mascha O., Zemva, Johanna, Larmann, Jan, Merle, Uta, Adamzik, Michael, Müller-Tidow, Carsten, Haferlach, Torsten, Leuschner, Florian, Weigand, Markus A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614713/
https://www.ncbi.nlm.nih.gov/pubmed/36311800
http://dx.doi.org/10.3389/fimmu.2022.968778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614713/
https://www.ncbi.nlm.nih.gov/pubmed/36311800
http://dx.doi.org/10.3389/fimmu.2022.968778

Ejemplares similares